A Short Review by Dr. Q. Ping Dou, on the eBook: Topics in Anti-Cancer Research – Volume 3 edited by Atta-ur-Rahman & Khurshid Zaman.

This is the third volume of the Patent eBook Series. This eBook comprises updated reviews on topics relevant to modern cancer research published in the journal Recent Patents on Anti-Cancer Drug Discovery. Specifically, regulation of tumor cells by TRAIL receptors, development of anti-cancer drugs & immunomodulatory drugs, molecular studies of adrenocortical cancer, role of inhibitors of inosine monophosphate dehydrogenase in cancer, recent updates in glioblastoma stem cells, latest approaches for cancer gene therapy and metabolic therapy for cancer were carefully reviewed and updated. In addition, the role of pH regulation and application of hyperthermia, thiosemicarbazone derivatives, tamoxifen-based therapies for cancer treatment andproteome-based complex therapy of tumors, calcium signaling and angiogenesis, antineoplastic role of GHRH antagonists and therapeutic applications in human tumors and clinical oncology have been extensively discussed in the light of recent innovations.

I believe that this volume is unique with the following distinctive features. (i) It is highly relevant to clinical treatment of patients with various cancers and the impact of this book should be very broad and significant. (ii) This is a topic, of extreme and timely interest in the field. (iii) This volume will have a general Interest. The comprehensive range of themes covered in this third volume will be of benefit to clinicians, scientists and R&D experts looking for new targets for the prevention of cancer and discovery of drugs for the treatment of different cancer types. The topics covered in this third volume will also be valuable for those interested in scientists interested in methods for the prevention of cancer as well its management.

Q. Ping Dou, Ph.D.
Barbara Ann Karmanos Cancer Institute
Departments of Oncology, Pharmacology and Pathology

World Leprosy Eradication Day 2015


banner-Leprosy-EradicationRelated journals:
Infectious Disorders – Drug Targets
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Current Immunology Reviews

A Short Video on Bentham Science Flagship Journal Current Gene Therapy

YouTube: http://bit.ly/1zci8cR
Access the complete journal here: http://bit.ly/1qtBwL6

Highlighted Article of the Journal Current Pharmaceutical Biotechnology

CPB-Articles_16-3For more information, click here: http://bit.ly/1nIzqKR

Highlighted Article of the Journal Current Pharmaceutical Biotechnology

CPB-Articles_16-1For more information, click here: http://bit.ly/1nIzqKR

Bentham Open Access Article


The article entitledMicroRNAs: Important Epigenetic Regulators in Osteoarthritis,” in the journal Current Genomics, 2014, 15, 481-484, is now open for all to view and access.

For article Information, please visit: http://bit.ly/1K2ZZiW
For journal information, please visit: http://bit.ly/1zaGrGr

New Issue: Adolescent Psychiatry, Volume 4 – Number 4

aps1 aps2

For more information: http://bit.ly/15SqN8Z

A Short Podcast From The Journal Inflammation & Allergy – Drug Targets

Watch a new podcast sent by Dr. Suneela::::::http://youtu.be/TI-aMS3NQE0::::: focusing on the article Design and Development of Novel Azo Prodrugs using Various Permutations and Combinations of 5- and 4-Aminosalicylic Acids for Inflammatory Bowel Disease: A Colon-Targeted Approach’from the journal Inflammation & Allergy – Drug Targets Volume 12, issue 5.

The article talks about Novel carrier-linked azo prodrugs of 4 and 5-aminosalicylic acids (4-ASA and 5-ASA respectively) using the same drugs as carriers in different permutations and combinations were designed for targeting colon affected with inflammatory bowel disease (IBD). Read more here

Recently Published Issue Of the Journal Current Hypertension Reviews

Current Hypertension Reviews publishes frontier reviews, original research articles and guest edited thematic issues on all the latest advances on hypertension and its related areas e.g. nephrology, clinical care, and therapy. The journal’s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians and researchers in the field of hypertension.
Following are the articles from the journal Current Hypertension Reviews, volume 10 issue 2:
  • Author(s): Biagio R. Di Iorio


Recently Published Issue Of the Journal Current Angiogenesis, 3 Issue 2

Current Angiogenesis is a cutting-edge, peer-reviewed journal which publishes expert reviews, original research articles, drug clinical trial studies, commentaries on angiogenesis-related papers besides novel methods on angiogenesis analysis, and special topics on angiogenesis, covering all aspects from preclinical to clinical research pertaining to both neoplastic and non-neoplastic disorders.

Clinical applications of angiogenesis include angiogenesis parameters in diagnosis and prognosis, biomarkers of angiogenesis as well as therapeutic promotion or inhibition of angiogenesis. A major aim of the journal is not only to provide comprehensive reviews of the latest developments in angiogenesis research but also to promote new ideas by presenting emerging research directions.

Angiogenesis, the growth of new blood vessels, plays an essential role in development, reproduction, and tissue repair. Pathological angiogenesis occurs not only in tumor development but also in a range of non-neoplastic conditions referred to as “angiogenesis-dependent” diseases. Thus, angiogenesis research offers a common ground for many diseases that would otherwise appear unrelated. Current Angiogenesis provides a unifying forum for critical reviews of this quickly moving and expanding field.

Editorial (Thematic Issue: Antiangiogenic Agents in the Management of Solid Malignancies)
Author: Nabil Ismaili

Article:Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer –
Author: Halima Abahssain, Sakina Sekkate, Sihame Lkhoyaali, Patricia Pautier, Hind M’Rabti and Hassan Errihani

Article :Angiogenesis and Angiogenic Inhibitors in Non Small Cell Lung Cancer
Author: Nawfel Mellas, Zineb Benbrahim and Abdul Rahman Jazieh

Article:Antiangiogenic Agents in the Treatment of HER2-Negative Metastatic breast Cancer: A Brief Review
Author: Nabil Ismaili

Article:argeting Angiogenesis in Gastro-Intestinal Non Colorectal Cancers; A Review
Author:                S.A. Brahmi, Y. Seddik and S. Afqir

Article:Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates
Author: Fadi El Karak, Hampig Raphael Kourie, Ralph Chebib, Samer Tabchi, Alain Daher, Joseph Kattan and Marwan Ghosn –

Article:Targeting Angiogenesis in Soft Tissue Sarcomas
Author: S. Arifi and J.Y. Blay

Article:Targeting Angiogenesis in Thyroid Cancer
Author: S. Lkhoyaali, S. Benhmida, M. Aitelhaj, M. Layachi, H. Abahssain, H.N. Ismaili and H. Errihani –

Article:Resistance to Antiangiogenic: Focus on Mechanism
Author: Essadi Ismail, Lalya Issam, Kaddouri Said, Belbaraka Rhizlane, Qacif Hassan, Zyani Mohamed and Patricia Pautier –

Article:Cardiac Toxicities of Antiangiogenic Therapies
Author: Zakaria Bazid, Lhouari Tarik, Athul Pathac and Nabil Ismaili –

for more information : http://bit.ly/1DzPm8z